Last reviewed · How we verify
NCT06358365
Enhancing Fluid Transfer Through the Skin, by Increased Sweat Rate, on Hemodialysis Patients
NA trial testing The AquaPass System in Acute Kidney Failure in 5 participants. Completed in 7 November 2023.
2 November 2023
Quick facts
| Lead sponsor | AquaPass Medical Ltd. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 5 |
| Start date | 29 March 2023 |
| Primary completion | 2 November 2023 |
| Estimated completion | 7 November 2023 |
| Sites | 1 location across Israel |
Drugs / interventions tested
- The AquaPass System
Conditions studied
- Acute Kidney Failure — all drugs for Acute Kidney Failure →
- Chronic Kidney Diseases — all drugs for Chronic Kidney Diseases →
Sponsor
AquaPass Medical Ltd.
Who can join
18 and older, any sex, with Acute Kidney Failure or Chronic Kidney Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To demonstrate safety and performance of AquaPass System for improving fluid balance in hemo-dialysis patients, by increasing fluid loss via the skin.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Harnessing the eccrine sweat glands for the management of interdialytic weight gain - a pilot study.
Armaly ZA, Nitzan Y, Chernin G, Aronson D. · · 2024 · cited 2× · PMID 39311621 · DOI 10.1080/0886022x.2024.2406392
Verify or expand the search:
- PubMed search for NCT06358365
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of The AquaPass System
Trials testing the same drug.
- NCT05843201 — AquaPass Device in Treatment of CHF Patients · NA · completed
- NCT04578353 — Effect of Enhanced Sweat Rate on the Safety and Edema Status of Chronic Edematous Patients · NA · completed
Other recruiting trials for Acute Kidney Failure
Currently open trials in the same condition.
- NCT04334707 — Kidney Precision Medicine Project · recruiting
- NCT03655561 — Lassa Fever Clinical Course and Prognostic Factors in Nigeria · active not recruiting
Other AquaPass Medical Ltd. trials
Trials by the same sponsor.
- NCT06360380 — Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System · NA · recruiting
- NCT05843201 — AquaPass Device in Treatment of CHF Patients · NA · completed
- NCT04578353 — Effect of Enhanced Sweat Rate on the Safety and Edema Status of Chronic Edematous Patients · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06358365 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by AquaPass Medical Ltd.
- Last refreshed: 3 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06358365.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing